Dose Tolerance for Stereotactic Body Radiation Therapy

Normal tissue complication probability (NTCP) results were detailed in the July 2001 issue of Seminars in Radiation Oncology1 for conventionally fractionated radiation therapy. After 7 years, an extensive collection of stereotactic ablative body radiotherapy (SABR) or stereotactic body radiation therapy (SBRT) dose-tolerance limits was presented in the October 2008 issue of Seminars in Radiation Oncology,2 but estimates of risk were not yet available. We now have sufficient data to combine the 2: NTCP for SBRT.
Source: Seminars in Radiation Oncology - Category: Cancer & Oncology Authors: Source Type: research